Evidence map›Paper›PMID 40624260›Full record

ArticleEJNMMI reports2025

Lung shunting and radiation pneumonitis after holmium-166 TARE: a case study.

Meike W M van Wijk, Marcel J R Janssen, Mark J Arntz, Bram H J Geurts, Laura A Michon, Eric T T L Tjwa, Joey Roosen, J Frank W Nijsen

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in EJNMMI reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Meike W M van WijkDepartment of Medical Imaging, Radboud University Medical Center, Nijmegen, The Netherlands. meike.vanwijk@radboudumc.nl.ORCID http://orcid.org/0000-0002-4626-6694
Marcel J R JanssenDepartment of Medical Imaging, Radboud University Medical Center, Nijmegen, The Netherlands.
Mark J ArntzDepartment of Medical Imaging, Radboud University Medical Center, Nijmegen, The Netherlands.
Bram H J GeurtsDepartment of Medical Imaging, Radboud University Medical Center, Nijmegen, The Netherlands.
Laura A MichonDepartment of Pulmonary Diseases, Radboud University Medical Center, Nijmegen, The Netherlands.
Eric T T L TjwaDepartment of Hepatology and Gastroenterology, Radboud University Medical Center, Nijmegen, The Netherlands.
Joey RoosenDepartment of Medical Imaging, Radboud University Medical Center, Nijmegen, The Netherlands.
J Frank W NijsenDepartment of Medical Imaging, Radboud University Medical Center, Nijmegen, The Netherlands.

Funding

Quirem Medical B.V. - a Terumo Company Quirem Medical B.V. - a Terumo Company
6 · The paper itself

Abstract

purposeThe assessment of the lung shunting fraction (LSF) in yttrium-90 (

methodsTwo patients with hepatocellular carcinoma received

resultsTwo patients without any pulmonary medical history received a lung dose of 13 Gy and 18 Gy due to a LSF of 9.8% and 7.1% based on SPECT after therapy. The patients showed both clinical and radiological signs of RP which resolved 3-4 months after TARE. Lung function testing showed no restriction or obstruction, but did show lowered diffusion.

conclusionWe present two relatively mild cases of RP after

Indexed as

Case report; radiation pneumonitisHolmium-166Lung dosimetryLung shuntingTransarterial radioembolization

Identifiers

PMID40624260
PMCPMC12234408

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.